Clinical TrialsSearch results
Number of results: 564
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Other
- Validation study VI of febrile neutropenia guideline 2004
- Febrile Neutropenia
- Japan Febrile Neutropenia Study Group
- 2006-08-04
Other
- Validation study of new febrile neutropenia guideline-Comparative study between oral levofloxacin and parenteral cefepime in low-risk patients with febrile neutropenia
- Febrile neutropenia
- Japan Febrile Neutropenia Study Group
- 2006-04-04
Other
- Validation of efficacy of cervical cerclage in patients with short cervical length
- Pregnant women with subclinical infection and cervical length 25 mm as diagnosed by transvaginal ultrasonography in a maternity health examination conducted during the second trimester of pregnancy (between week 16 day 0 and week 26 day 6 of gestation)
- Japan Organization of Prevention of Preterm Delivery
- 2009-04-20
Other
- Urinary Angiotensinogen as a Marker of Intrarenal Angiotensin II Activity in Patients with Chronic Renal Disease
- Chronic renal diseases
- Hamamatsu University School of Medicine
- 2005-09-13
Other
- Unruptured Cerebral Aneurysm Study in Japan
- Unruptured intracranial aneurysms
- Society of Japan Neurosurgical Society
- 2006-05-17
Recruiting
- TWICE trial
- colorectal adenomas, colorectal cancer
- Imai Kenichiro
- 2023-05-24
Other
- Treatment for steroid-resistant nephrotic syndrome in children: a combination of cyclosporine and prednisolone in minimal change and a combination of methylprednisolone, cyclosporine and prednisolone in FSGS
- Steroid-resistant nephrotic syndrome in children
- Japanese Study Group of Renal Disease in Children
- 2005-08-01
Recruiting
- TRANSIT study
- Obstructive colorectal cancer
- Hotta Kinichi
- 2022-03-04
Other
- Transdermal administration of morphine to the patients with pain
- Patients with pain
- Department of Clinical Pharmacology and Therapeutics
- 2009-06-01
Other
- To evaluate whether two weekly concurrent chemoradiotherapy regimens offer any advantage over concurrent chemoradiotherapy regimens with Cisplatin, Vindesine, Mitomycin for unresectable stage III NSCLC
- unresectable stage III NSCLC
- West Japan Oncology Group
- 2005-08-29